Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
---|
07/03/2003 | US20030125242 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
07/03/2003 | US20030124662 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/03/2003 | US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof |
07/02/2003 | EP1263327A4 Biocompatible material composition adaptable to diverse therapeutic indications |
06/26/2003 | WO2003051910A2 Inhibitors of hepatitis c virus protease |
06/26/2003 | US20030120045 Immobilization onto polyoxyethylene glycol |
06/26/2003 | US20030119110 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/26/2003 | US20030119106 Fusion proteins; binding to antibodies |
06/26/2003 | US20030119103 Fusion proteins; binding to antibodies |
06/26/2003 | US20030119011 Arrays for detecting nucleic acids |
06/26/2003 | US20030119008 Nucleotides and analogs having photoremovable protecting groups |
06/25/2003 | EP1321772A1 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine |
06/24/2003 | US6583272 Protein conjugate for use in the treatment of blood disorders |
06/24/2003 | US6582926 Solid support for use as analytical tool in genetic engineering |
06/24/2003 | CA2012311C New protein-polycation-conjugate |
06/19/2003 | WO2003050544A2 Methods for protein analysis using protein capture arrays |
06/19/2003 | WO2003049760A1 Compositions and method for treating hepatitis virus infection |
06/19/2003 | US20030113843 For stimulating release of tumor necrosis factor, and/or cell proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; antiinflammatory agents; anticarcingenic agents; antitumor agents; cancer diagnosis |
06/19/2003 | CA2470083A1 Methods for protein analysis using protein capture arrays |
06/18/2003 | EP1319954A1 Methods for protein analysis using protein capture arrays |
06/18/2003 | EP1319953A1 Particles for immunoassays and methods for treating the same |
06/18/2003 | EP1318827A1 Polymer-modified synthetic proteins |
06/18/2003 | EP1212095B1 Process to make a sustained release formulation |
06/12/2003 | US20030109003 Antitumor agent; transformation of expression vector; genetic engineering; process control hybrids |
06/12/2003 | US20030108899 Detection hybrids; masking biosynthesis; photosensitive blocking agents; determination accumulated fluorescence radiation |
06/12/2003 | US20030108550 Anti-procalcitonin antibodies and the preparation and use thereof |
06/12/2003 | CA2811997A1 Antibodies against monocyte chemotactic proteins |
06/11/2003 | EP0779894B1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
06/10/2003 | US6576424 Solid support for use in the determination, classification and mapping of biopolymer sequences |
06/10/2003 | US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus |
06/05/2003 | WO2003045980A2 Glycopeptide remodeling using amidases |
06/05/2003 | WO2003045975A2 Solid-phase immobilization of proteins and peptides |
06/05/2003 | US20030104557 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; cancer diagnosis |
06/05/2003 | US20030104556 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104555 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104554 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypetide; cancer diagnosis |
06/05/2003 | US20030104550 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104549 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104545 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104544 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
06/05/2003 | US20030104411 Microarray for use in analysis and classification of biological samples |
06/05/2003 | US20030104360 Synthetic receptors, libraries and uses thereof |
06/05/2003 | US20030103990 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
06/05/2003 | US20030103936 Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides |
06/05/2003 | CA2468230A1 Glycopeptide remodeling using amidases |
06/04/2003 | EP1316562A2 Composition comprising a covalent polyethylene glycol (PEG)-protein adduct |
06/04/2003 | EP1315513A2 "pseudo"-native chemical ligation |
06/04/2003 | EP1315511A2 Synthetic erythropoiesis stimulating proteins |
06/04/2003 | CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof |
06/03/2003 | US6573003 Soluble recombinant fusion protein comprising a nontoxin protein sequence and portion of Clostridium difficile toxin B amino acid sequence 10; pseudomembranous enterocolitis; side effect free; low cost |
05/30/2003 | WO2003044056A2 Chemically-modified human growth hormone conjugates |
05/30/2003 | WO2002076485A3 Vaccine for modulating between t1 and t2 immune responses |
05/30/2003 | CA2467731A1 Chemically-modified human growth hormone conjugates |
05/29/2003 | US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders |
05/29/2003 | US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
05/29/2003 | US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100004 Solid supportfor us ein the detection of preferential particles in sample |
05/28/2003 | EP1313863A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
05/28/2003 | EP1313440A1 Dental products comprising bone growth enhancing peptide |
05/28/2003 | CN1420793A Absorbents for dilated cardiomyopathy |
05/27/2003 | US6569993 Process for the preparation of resin-bound cyclic peptides |
05/27/2003 | CA2176229C Improved interferon polymer conjugates |
05/22/2003 | WO2001015736A3 Interferon-beta conjugates |
05/22/2003 | US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder |
05/22/2003 | US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/22/2003 | US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/22/2003 | US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/22/2003 | US20030096354 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
05/22/2003 | US20030096320 Oil bodies and associated proteins as affinity matrices |
05/21/2003 | EP1312671A1 Magnetic particles having lower limit critical solution temperature |
05/21/2003 | EP1312627A1 Polymers |
05/21/2003 | EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
05/21/2003 | EP0575545B1 Pegylation of polypeptides |
05/21/2003 | CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates |
05/20/2003 | US6566506 Useful in extending the in vivo circulating life of biologically active materials |
05/20/2003 | US6566504 Adding to the protein solution a cyclodextrin in an amount sufficient to form a stable complex with the protein, lyophilizing, recovering lyophilized protein/cyclodextrin complex, heating complex to inactivate viruses |
05/20/2003 | US6566495 Biosynthesis of preferential biopolymers; provide substrate, electrically activate preferential positions, bind monomer, repeat, recover biopolymers |
05/20/2003 | US6565857 Coding human leukocyte antigen; anticancer, antitumor agent |
05/15/2003 | WO2003040726A2 Screening for hepatitis c virus entry inhibitors |
05/15/2003 | US20030092800 Sustained release; drug delivery |
05/15/2003 | US20030092147 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
05/15/2003 | US20030092122 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
05/15/2003 | US20030092115 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/15/2003 | US20030092113 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/15/2003 | US20030092111 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/15/2003 | US20030092110 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/15/2003 | US20030092108 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
05/15/2003 | US20030092107 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
05/15/2003 | US20030092106 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/15/2003 | US20030092105 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
05/15/2003 | US20030092104 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
05/15/2003 | US20030092103 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/15/2003 | CA2465731A1 Screening for hepatitis c virus entry inhibitors |
05/14/2003 | EP1310795A1 Chemical sensor and method of detecting chemical |
05/14/2003 | EP1310510A2 Topologically segregated, encoded solid phase libraries |
05/13/2003 | US6562961 Aminoalkyl trialkyl silyl cellulose and a method for coating surfaces |
05/13/2003 | CA2096933C Compounds and compositions which inhibit bone resorption |
05/08/2003 | WO2003038033A2 Protein and peptide nanoarrays |
05/08/2003 | WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy |
05/08/2003 | US20030087458 Preparing particles for immunoassays; obtain N-hydroxysuccinimide or N-hydroxysulfosuccinimide and react with particles, incubate with antibodies, recover particles |